These effects, along with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two help the notion of concentrating on ACKR3 as a novel way to modulate the opioid system, which could open up new therapeutic avenues for opioid-relevant disorders. Disclaimer: The above is https://chandrao169ied6.blog2news.com/profile